Manning & Napier Advisors LLC reduced its stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 8.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 73,059 shares of the medical instruments supplier's stock after selling 6,544 shares during the period. Manning & Napier Advisors LLC's holdings in Becton, Dickinson and Company were worth $16,575,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also modified their holdings of the company. Sound Income Strategies LLC increased its stake in Becton, Dickinson and Company by 35.8% during the 3rd quarter. Sound Income Strategies LLC now owns 167 shares of the medical instruments supplier's stock worth $40,000 after purchasing an additional 44 shares in the last quarter. Central Pacific Bank Trust Division increased its position in shares of Becton, Dickinson and Company by 22.5% during the third quarter. Central Pacific Bank Trust Division now owns 245 shares of the medical instruments supplier's stock worth $59,000 after acquiring an additional 45 shares in the last quarter. Tompkins Financial Corp raised its holdings in shares of Becton, Dickinson and Company by 44.2% during the third quarter. Tompkins Financial Corp now owns 150 shares of the medical instruments supplier's stock worth $36,000 after acquiring an additional 46 shares during the period. Birch Capital Management LLC lifted its position in Becton, Dickinson and Company by 0.4% in the 3rd quarter. Birch Capital Management LLC now owns 11,773 shares of the medical instruments supplier's stock valued at $2,838,000 after acquiring an additional 48 shares in the last quarter. Finally, Radnor Capital Management LLC increased its holdings in Becton, Dickinson and Company by 1.7% during the 3rd quarter. Radnor Capital Management LLC now owns 2,937 shares of the medical instruments supplier's stock worth $708,000 after purchasing an additional 48 shares in the last quarter. 86.97% of the stock is owned by institutional investors and hedge funds.
Becton, Dickinson and Company Stock Up 0.5 %
BDX traded up $1.13 during trading on Wednesday, reaching $250.21. 187,558 shares of the stock were exchanged, compared to its average volume of 1,881,035. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.74 and a current ratio of 1.17. The stock's 50 day moving average price is $229.10 and its two-hundred day moving average price is $233.46. Becton, Dickinson and Company has a twelve month low of $218.75 and a twelve month high of $250.91. The stock has a market cap of $72.56 billion, a P/E ratio of 42.20, a price-to-earnings-growth ratio of 1.72 and a beta of 0.39.
Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $3.81 earnings per share for the quarter, topping the consensus estimate of $3.77 by $0.04. Becton, Dickinson and Company had a net margin of 8.55% and a return on equity of 14.89%. The company had revenue of $5.44 billion for the quarter, compared to analyst estimates of $5.38 billion. During the same period in the previous year, the business earned $3.42 EPS. Becton, Dickinson and Company's revenue for the quarter was up 6.9% compared to the same quarter last year. Equities analysts expect that Becton, Dickinson and Company will post 14.42 EPS for the current year.
Becton, Dickinson and Company announced that its Board of Directors has initiated a share buyback plan on Tuesday, January 28th that allows the company to repurchase 10,000,000 shares. This repurchase authorization allows the medical instruments supplier to reacquire shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company's board believes its stock is undervalued.
Becton, Dickinson and Company Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 10th will be given a $1.04 dividend. This represents a $4.16 dividend on an annualized basis and a dividend yield of 1.66%. Becton, Dickinson and Company's payout ratio is 70.03%.
Insider Transactions at Becton, Dickinson and Company
In other Becton, Dickinson and Company news, EVP Roland Goette sold 638 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $219.03, for a total value of $139,741.14. Following the transaction, the executive vice president now directly owns 14,217 shares of the company's stock, valued at $3,113,949.51. This represents a 4.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael David Garrison sold 2,838 shares of the business's stock in a transaction that occurred on Thursday, December 19th. The stock was sold at an average price of $223.33, for a total value of $633,810.54. Following the sale, the executive vice president now owns 6,141 shares of the company's stock, valued at approximately $1,371,469.53. This represents a 31.61 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 9,844 shares of company stock worth $2,210,716. 0.36% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of analysts have recently commented on the company. Citigroup upgraded Becton, Dickinson and Company from a "neutral" rating to a "buy" rating and boosted their price target for the company from $255.00 to $275.00 in a report on Tuesday, October 1st. Evercore ISI upped their price target on Becton, Dickinson and Company from $286.00 to $290.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 1st. StockNews.com downgraded shares of Becton, Dickinson and Company from a "buy" rating to a "hold" rating in a report on Wednesday, December 18th. Finally, Piper Sandler raised their target price on shares of Becton, Dickinson and Company from $275.00 to $280.00 and gave the company an "overweight" rating in a research report on Tuesday. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Becton, Dickinson and Company presently has an average rating of "Moderate Buy" and a consensus price target of $283.00.
Check Out Our Latest Stock Report on Becton, Dickinson and Company
About Becton, Dickinson and Company
(
Free Report)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
Featured Stories
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Becton, Dickinson and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Becton, Dickinson and Company wasn't on the list.
While Becton, Dickinson and Company currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
